US
Patent Prosecution
Patent Strategy & Management
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Jarrell, Brenda H | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation | Boston |
| Lyon, Charles | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation | Boston |
| Marandett, Eric | Intellectual Property | Hatch-Waxman Patent Litigation, Patent Strategy & Management, General Patent Litigation | Boston |
| Medina, Rolando | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Boston |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Choate Hall & Stewart
Boston firm Choate Hall & Stewart is well known for its expertise in patent prosecution and strategy for life sciences clients, earning top ranking in these areas. The firm also has a significant practice focused on pharmaceutical patent litigation. "You know you're in good hands there," a peer says about the firm's prosecution group.
Life sciences co-chair Brenda Jarrell is a leader at the firm with a national reputation as a patent strategist. "She's wonderful," a peer says. "I have nothing but good things to say about her." Another peer adds, "I think she is doing an outstanding job." Jarrell currently advises Wave Life Sciences in prosecution matters related to its genetic medicine portfolios. She was shortlisted by LMG Life Sciences for the Massachusetts Patent Strategy & Management Attorney of the Year award in 2019. IP co-chair Charles Lyon focuses his practice on patent counseling and strategy. He and partner Rolando Medina are currently advising a client in the gene editing space.
In the litigation group, co-chair Eric Marandett continues to be active for a number of clients in patent disputes. "He is really handling some of the most significant cases that are being done," a competitor says. Marandett recently acted for Takeda in a legacy Shire matter at the Federal Circuit related to an enzyme replacement therapy patent. The appeal was dismissed in favor of the client.